PFM Health Sciences’s Tesla TSLA Stock Holding History

PFM Health Sciences’s Portfolio TSLA Stock Details TSLA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-1,088,055	Closed	-$19.3M	–	124
2018 Q1	$19.3M	Sell	1,088,055 -152,445	-12%	-$3.35M	0.39%	72
2017 Q4	$25.7M	Buy	+1,240,500	New	+$27M	0.61%	57

Other funds holding TSLA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

PFM Health Sciences's TSLA Position: Q2 2018 in Review

PFM Health Sciences sold out of Tesla (TSLA) in Q2 2018, closing a stake of 1,088,055 shares — an estimated $19.3M sold.

PFM Health Sciences first reported a position in TSLA in Q4 2017 and held it in 2 quarters. The position peaked at $25.7M in Q4 2017. 781 funds tracked by Wall St. Rank hold TSLA as of Q2 2018.

PFM Health Sciences reported no remaining Tesla position as of Q2 2018 after selling out during the quarter.
PFM Health Sciences sold 1,088,055 Tesla shares in Q2 2018, an estimated $19.3M.
PFM Health Sciences first reported a position in Tesla in Q4 2017 and held it in 2 quarters.
PFM Health Sciences's Tesla position peaked at $25.7M in Q4 2017.
781 funds tracked by Wall St. Rank held Tesla as of Q2 2018.

Based on PFM Health Sciences's 13F filing for Q2 2018, filed 14 Aug 2018.